News about Drug Discovery & Development

Sanofi Signs Co-Exclusive Licensing Deal with Novavax to Co-Commercialize COVID-19 Vaccine

Sanofi has signed a co-exclusive licensing agreement with Novavax, a biotechnology company headquartered in Maryland, US.

Drug Discovery & Development | 10/05/2024 | By Aishwarya |  391

Zydus Completes Enrolment for EPICS IIITM Phase 2b/3 Trial of Saroglitazar Mg

Zydus Lifesciences has completed enrolment of Phase 2b/3 EPICS IIITM trial of Saroglitazar Mg in patients with Primary Biliary Cholangitis (PBC).

Drug Discovery & Development | 10/05/2024 | By Aishwarya |  575

Field Medical Announces First-in-Human Trials for Groundbreaking FieldForce Ventricular Pulsed Field Ablation Technology

The VCAS investigational study is a critical step towards demonstrating safety and performance of the FieldForce™ Ablation System, developed specifically to address the limitations of existing pulsed field ablation (PFA) and radiofrequency (RF) ablation systems, including a more time efficient treatment protocol for the treatment of ventricular arrhythm

Drug Discovery & Development | 09/05/2024 | By Manvi |  445

BioVersys Extends its Strategic Collaboration with GSK

BioVersys has extended its strategic collaboration with the global biopharma company GSK to accelerate the clinical development of alpibectir (BVL-GSK098) for the treatment of tuberculosis (TB).

Drug Discovery & Development | 09/05/2024 | By Aishwarya |  802

Anixa Biosciences Signs JDA with Cleveland Clinic to Develop Novel Vaccines for Various Cancer Types

The vaccines focus on a novel scientific mechanism never used before in a cancer vaccine.

Drug Discovery & Development | 08/05/2024 | By Manvi |  445

Selvita Acquires PozLab to Expand its Drug Development Capabilities

Selvita has completed a strategic transaction in which it has acquired 100% of shares in PozLab.

Drug Discovery & Development | 08/05/2024 | By Aishwarya |  582

ARTBIO and Nucleus to Manufacture GMP-Grade Therapeutic Products

ARTBIO, Inc. has announced a strategic manufacturing and supply agreement with Nucleus RadioPharma Inc. to support ARTBIO’s therapeutic product manufacturing.

Drug Discovery & Development | 08/05/2024 | By Aishwarya |  468

Gossamer Bio Partners with Chiesi to Develop and Commercialize Seralutinib

Gossamer Bio, Inc. has signed a global collaboration and license deal with Chiesi Farmaceutici to develop and commercialize seralutinib.

Drug Discovery & Development | 07/05/2024 | By Aishwarya |  399

Vesica Health Announces Launch of AssureMDx Test to Improve Bladder Cancer Detection

VESICA HEALTH, INC., a multi-omics liquid biopsy company dedicated to improving the management of hematuria patients and the early detection of bladder cancer, announced the launch of its laboratory-developed AssureMDx™ test.

Drug Discovery & Development | 06/05/2024 | By Manvi |  683

Lupin Introduces Rymti Biosimilar Etanercept in Canada

Lupin Ltd. has developed Rymti, Lupin’s first biosimilar in Canada, through its partner Sandoz Canada (Sandoz).

Drug Discovery & Development | 06/05/2024 | By Aishwarya |  640